{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:08:51Z","timestamp":1775034531625,"version":"3.50.1"},"reference-count":27,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1136\/bjophthalmol-2014-306319","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T04:05:15Z","timestamp":1423800315000},"page":"1055-1059","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":74,"title":["Ziv-aflibercept in macular disease"],"prefix":"10.1136","volume":"99","author":[{"given":"Ahmad M","family":"Mansour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara I","family":"Al-Ghadban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad H","family":"Yunis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan E","family":"El-Sabban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2014-306319-1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/bjophthalmol-2014-305149","article-title":"Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis","volume":"99","author":"Schmid","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306319-3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306319-4","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/IAE.0000000000000182","article-title":"Retina specialists treating age-related macular degeneration recommend different approaches for patients than they would choose for themselves","volume":"34","author":"Jeng","year":"2014","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2014-306319-5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2014.6672","article-title":"Drugs for macular degeneration, price discrimination, and Medicare's responsibility not to overpay","volume":"312","author":"Silver","year":"2014","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2014-306319-6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40123-013-0015-2","article-title":"Aflibercept for the treatment of age-related macular degeneration","volume":"2","author":"Trichonas","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"key-10.1136\/bjophthalmol-2014-306319-7","first-page":"488","article-title":"Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients","volume":"18","author":"Ng","year":"2012","journal-title":"Hong Kong Med J"},{"key":"key-10.1136\/bjophthalmol-2014-306319-8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/jop.2008.0043","article-title":"Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months","volume":"25","author":"Chen","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2014-306319-9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1345\/aph.1L270","article-title":"Bevacizumab sterility in multiple doses from a single-use vial","volume":"42","author":"Ornek","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.1136\/bjophthalmol-2014-306319-10","first-page":"1016","article-title":"Osmotically induced retinal detachment in the rabbit and primate. Electron miscoscopy of the pigment epithelium","volume":"19","author":"Marmor","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306319-11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1520\/JFS173720387","article-title":"Osmolality and other chemical determinations in postmortem human vitreous humor","volume":"17","author":"Sturner","year":"1972","journal-title":"J Forensic Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306319-12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1520\/JFS2003152","article-title":"Measurement of chemical analytes in vitreous humor: Stability and precision studies","volume":"49","author":"Gagajewski","year":"2004","journal-title":"J Forensic Sci"},{"issue":"(Suppl 1)","key":"key-10.1136\/bjophthalmol-2014-306319-13","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1136\/bjophthalmol-2014-305302","article-title":"Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture","volume":"98","author":"Malik","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/bjophthalmol-2014-305105","article-title":"Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis","volume":"98","author":"Klettner","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3928\/23258160-20141118-15","article-title":"Preclinical investigations of intravitreal ziv-aflibercept","volume":"45","author":"de Oliveira Dias","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2014-306319-16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajo.2006.03.036","article-title":"Intravitreal avastin: the low cost alternative to lucentis?","volume":"142","author":"Rosenfeld","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ophtha.2013.10.037","article-title":"Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration","volume":"121","author":"Stein","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306319-18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bjo.2007.116616","article-title":"Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness","volume":"91","author":"Raftery","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaophthalmol.2014.3591","article-title":"Evaluation of compounded bevacizumab prepared for intravitreal injection","volume":"133","author":"Yannuzzi","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharma.2012.03.006","article-title":"Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration","volume":"70","author":"Paul","year":"2012","journal-title":"Ann Pharm Fr"},{"key":"key-10.1136\/bjophthalmol-2014-306319-21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1389201015666140619120834","article-title":"Quantification, microbial contamination, physico-chemical stability of repackaged bevacizumab stored under different conditions","volume":"15","author":"Signorello","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/eye.2013.139","article-title":"Quality of bevacizumab compounded for intravitreal administration","volume":"27","author":"Palmer","year":"2013","journal-title":"Eye"},{"key":"key-10.1136\/bjophthalmol-2014-306319-23","first-page":"495","article-title":"Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration","volume":"7","author":"Thomas","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1167\/iovs.13-13054","article-title":"Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes","volume":"55","author":"Ahn","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306319-25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-013-2495-0","article-title":"Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes","volume":"252","author":"Moisseiev","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306319-26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ophtha.2012.11.018","article-title":"Aflibercept-related sterile inflammation","volume":"120","author":"Hahn","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306319-27","first-page":"564","article-title":"Stability of preoperative cataract surgery gel in polycarbonate syringes","volume":"13","author":"Bailey","year":"2009","journal-title":"Int J Pharm Compd"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2014-306319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:49:31Z","timestamp":1601110171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2014-306319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,7,21]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1136\/bjophthalmol-2014-306319"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306319","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}